Kardigan (KARD) has priced its initial public offering of 25 million shares at $16 each for gross proceeds of about $400 million, the therapeutics company said late Wednesday.
The company said it has granted the underwriters a 30-day option to purchase up to an additional 3.8 million shares.
Shares are expected to begin trading on the Nasdaq Global Market on Thursday under the ticker "KARD."
The offering is expected to close on June 22.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.